Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants (Q42222163)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2014
edit
Language Label Description Also known as
English
Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants
scientific article published on January 2014

    Statements

    Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants (English)
    Martin Fisher
    Brian Gazzard
    Peter Ruane
    Jan Van Lunzen
    David Shamblaw
    Jason Flamm
    Ramin Ebrahimi
    Kirsten White
    Jason Hindman
    Elizabeth Elbert
    Shampa De-Oertel
    Todd Fralich
    1 January 2014
    335-344

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit